Neuro-ophthalmologyNovaVision: vision restoration therapyMcFadzean, Robert M Author Information Institute of Neurological Sciences and Tennent Institute of Ophthalmology, University of Glasgow, Glasgow, UK Correspondence to Dr R.M. McFadzean, Department of Neuro-Ophthalmology, Southern General Hospital, Govan Road, Glasgow G51 4TF, United Kingdom Tel: +44 141 201 1995; e-mail: [email protected] Current Opinion in Ophthalmology: December 2006 - Volume 17 - Issue 6 - p 498-503 doi: 10.1097/ICU.0b013e3280108544 Buy Metrics Abstract Purpose of review The aim of this article is to review the controversial findings for NovaVision's vision restoration therapy. Recent findings It has been claimed that NovaVision's computerized therapy results in expansion of the visual field in optic nerve and occipital lesions, but the outcome has been challenged on the grounds of unsatisfactory perimetric control of central fixation and disputed mechanisms. Summary In clinical practice NovaVision's therapy should not currently gain acceptance in view of unacceptable perimetric standards and equivocal results. Possible effects on a relative scotoma at the edge of a lesion have not been adequately explored. In the interim, research should also be focused on compensatory eye movement strategies. © 2006 Lippincott Williams & Wilkins, Inc.